Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases March 05, 2026 Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update February 26, 2026 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 January 06, 2026 Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview (March 5, 2026) 4.8 MB Roche Pharma Day 2025 Presentation 8.1 MB OpRegen® 3 Year Clinical Data Update (Clinical Trials at the Summit 2025) 945.1 KB Fourth Quarter and Full Year 2025 Financial Results Earnings Call Mar 5, 2026 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
March 05, 2026 Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 26, 2026 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
January 06, 2026 Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience
Fourth Quarter and Full Year 2025 Financial Results Earnings Call Mar 5, 2026 at 4:30 PM EST Click here for webcast
